Furthermore, by using S64846, an MCL-1-specific inhibitor, we found that MCL-1 inhibition in M2 CM-treated cancer cells increased apoptosis and decreased EMT marker expression (Supplementary Fig. 3A). Here, MCL1 is linked to cancer.